DURHAM, N.C.
Merix Bioscience Inc. will relocate in summer 2001 from an incubator at Becton Dickinson in Research Triangle Park, N.C., to a 20,000-sf Durham facility, formerly owned by Rhone Poulenc Rorer. Merix plans to conduct clinical trials of its new cancer vaccine at the facility.